Speakers

• Antoine Alam VP Head of Virology
  Antoine Alam

  VP Head of Virology

  With over 20 years of experience in the field, Antoine Alam bring extensive knowledge in virology and immunology to Just – Evotec Biologics. He has received a Ph.D. in Immunology from the Université Paul Sabatier Toulouse III.

• Cristina Loomis Principal Scientist, Antibody Discovery
  Cristina Loomis

  Principal Scientist, Antibody Discovery

  In her 10+ years of experience Cristina has accumulated extensive biopharmaceutical industry experience in discovery and preclinical development of therapeutic antibodies and biologics. She has contributed to preclinical work for the progression of numerous therapeutics that were brought forward to clinical development, including two immune-oncology and two migraine treatment drugs. Christina is specialized in preclinical development, in vitro and in vivo pharmacology, in vivo fluorescence microscopy, immune-oncology, immunological assays and neurobiology. She has received her PhD in Immunology from McGill University.

• Randal Ketchem SVP Discovery and Molecular Design
  

  Randal Ketchem

  SVP Discovery and Molecular Design

  Randy received his PhD in Molecular Biophysics from Florida State University, focusing on experimental protein structure determination, resulting in the first membrane-bound protein structure solved by Solid State NMR. As part of this effort he developed computational methods for the structure calculation and refinement of membrane-bound proteins. Randy continued his training in structural biology in a postdoctoral fellowship at The Scripps Research Institute where he expanded his experimental and computational efforts into solution-based protein structure. Randy then joined Immunex in 1997 to apply his expertise in protein structure modelling and analysis to efforts in the development of biologic-based therapeutics. During his many years of experience at Immunex, Amgen, and Just Biotherapeutics he has led efforts to engineer protein therapeutics, invented novel therapeutic modalities and computational methods for therapeutic design, and developed computational and experimental approaches to understanding and controlling biophysical properties of biological macromolecules. Randy has made significant contributions in antibody design, epitope mapping, molecular assessment, stability engineering, construct design, protein structure analysis, and protein engineering. At Just – Evotec Biologics, Randy leads the Molecular Design team, integrating biologics discovery and molecular design strategies into the entire therapeutic pipeline.